Key result
Metabolic syndrome linked to attenuated GLS improvement after septal myectomy for hypertrophic obstructive cardiomyopathy.
Why the study?
MetS increases the risk of cardiovascular disease, but its impact on myocardial fibrosis, left heart function, and postoperative reverse remodeling in HOCM patients undergoing SM was evaluated.
Does metabolic syndrome impair postoperative myocardial recovery and reverse remodeling in patients with hypertrophic obstructive cardiomyopathy undergoing septal myectomy?
Cohort (n=305)
No
Does metabolic syndrome impair postoperative myocardial recovery and reverse remodeling in patients with hypertrophic obstructive cardiomyopathy undergoing septal myectomy?
The presence of metabolic syndrome in patients with hypertrophic obstructive cardiomyopathy is associated with worse baseline myocardial function and independently predicts diminished structural and functional recovery following septal myectomy.
Answers are grounded in this paper and cite their sources.
MetS may attenuate GLS recovery after myectomy in HOCM; hypothesis-generating and warrants prospective trials before changing practice.
Background: Metabolic syndrome (MetS) is a cluster of metabolic abnormalities that increase the risk of cardiovascular disease. This study evaluated the impact of MetS on myocardial fibrosis, left heart function, and postoperative reverse remodeling in hypertrophic obstructive cardiomyopathy (HOCM) patients undergoing septal myectomy (SM). Methods: A total of 305 consecutive patients with HOCM (120 with MetS and 185 without MetS) who underwent SM with comprehensive pre- and postoperative cardiac magnetic resonance (CMR) evaluations between April 2022 and December 2024 were included in this study. CMR-derived structural, functional, and fibrosis-related parameters were analyzed. Multivariable linear regression identified determinants of the rate of change in global longitudinal strain (GLS) and left atrial (LA) strain. Results: Compared with the HOCM patients without MetS, those with MetS exhibited lower global radial strain (GRS), GLS, and left ventricular global function index (LVGFI) values, along with higher left ventricular mass index (LVMI), left ventricular remodeling index (LVRI), and myocardial fibrosis burden values (all P<0.05). Regarding LA function, the HOCM patients with MetS had larger left atrial volume index (LAVI) and left atrioventricular coupling index (LACI) values, lower total left atrial emptying fraction (LAEF), and impaired LA total and passive strain (all P<0.05). The multivariable analysis identified the presence of MetS as an independent determinant of postoperative changes in GLS (β=0.264, P<0.001) and total strain (εs; β=0.135, P=0.030). Conclusions: The presence of MetS worsens left heart dysfunction and myocardial fibrosis in HOCM patients, and independently impairs myocardial recovery and reverse remodeling following SM. These findings highlight the importance of the early detection and comprehensive management of metabolic risk factors to improve surgical outcomes in HOCM patients with MetS.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2026) conducted a cohort in Hypertrophic obstructive cardiomyopathy (HOCM) (n=305). Metabolic syndrome vs. No metabolic syndrome was evaluated on Postoperative rate of change in global longitudinal strain (ΔGLS%) (β=0.264, p=<0.001). The presence of metabolic syndrome was an independent predictor of attenuated postoperative improvement in global longitudinal strain following septal myectomy in patients with hypertrophic obstructive cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: